| 2018-10-22 | Aclaris Therapeutics, Inc. ACRS | director | 744,186 1.6472% | $10.75 | $8M | -52.67% | ||
| 2017-01-10 | Sale | Aclaris Therapeutics, Inc. ACRS | director | 1.5M 5.5549% | $28.25 | $42.38M | -9.62% | |
| 2016-10-20 | Sale | Marinus Pharmaceuticals, Inc. MRNS | 10 percent owner | 1.5M 8.1026% | $1.39 | $2.09M | +3.79% | |
| 2015-10-13 | Aclaris Therapeutics, Inc. ACRS | 818,180 4.0506% | $11.00 | $9M | +61.56% | |||
| 2014-08-05 | Marinus Pharmaceuticals, Inc. MRNS | 1.5M 15.7118% | $8.00 | $12.01M | +9.89% |